Education

A short, animated video explaining the neurobiology and psychopharmacology of opioid addiction, including the effects of chronic exposure, the brain areas involved, and the development of withdrawal.

Chair: Prof. Icro Maremmani

Learning objective: After watching this video, learners will be able to describe the neurobiological and psychopharmacological aspects of opioid addiction.

Disclosures: The faculty declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

A presentation and discussion of the prevalence, epidemiology, risk factors, mortality and economic impact of opioid addiction in the EU.

Presenter: Dr Mercedes Lovrečič

Chair: Prof. Icro Maremmani

Learning objective: After watching this video, learners will be able to describe the burden of opioid dependence in the EU.

Disclosures: The faculty declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

A case study discussion of how to adjust a patient’s regimen of opioid agonist therapy. 

Presenter: Dr Andrej Kastelic

Learning objective: After watching this video, learners will be able to identify buprenorphine formulations available in Europe and considerations for therapy selection. 

Disclosures: Dr Andrej Kastelic declares speaker fees for Indivior, Inspharm and Gilead.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

An international expert panel discuss recent and future developments in the landscape of opioid addiction. 

Panellists: Dr Adrian Octavian Abagiu, Prof. Marc Auriacombe, Prof. Marta Torrens, Dr Stephan Walcher.

Learning objective: After watching this video, learners will be able to describe recent and anticipated developments in managing opioid use disorder.

Disclosures: Prof. Marc Auriacombe declares grants and speaker bureau membership from Indivior. Prof. Marta Torrens declares consultant fees for Camurus and Sixmo. All other faculty members declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

An expert discussion of strategies to identify and reduce misuse and diversion of OAT medication.

Panellists: Dr Adrian Octavian Abagiu, Prof. Marc Auriacombe, Prof. Marta Torrens, Dr Stephan Walcher

Learning objective: After watching this video, learners will be able to recall strategies to reduce misuse and diversion of OAT medication.

Disclosures: Prof. Marc Auriacombe declares grants and speaker bureau membership from Indivior. Prof. Marta Torrens declares consultant fees for Camurus and Sixmo. All other faculty members declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

A panel of international experts discuss the impact of stigma on treatment access and how to address it.

Panellists: Dr Milazim Gjocjaj, Dr Martin Haraldsen, Dr Albrecht Ulmer, Dr Peter Vossenberg

Learning objective: After watching this video, learners will be able to describe the importance of addressing stigma in opioid agonist therapy (OAT)

Disclosures: The faculty declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

An expert panel discussion of trends in patient preference and how clinicians can work with patients to best accommodate their treatment preferences. 

Panellists: Dr Milazim Gjocjaj, Dr Martin Haraldsen, Dr Albrecht Ulmer, Dr Peter Vossenberg

Learning objective: After watching this video, learners will be able to explain how to incorporate patient preference into treatment 

Disclosures: The faculty declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

An expert panel discuss the importance of opioid agonist therapy, as well as its economic implications.

Panellists: Dr Gabriele Fischer, Prof. Liljana Ignjatova, Dr Andrej Kastelic

Learning objective: After watching this video, learners will be able to evaluate the value of OAT in health systems 

Disclosures: Dr Andrej Kastelic declares speaker fees for Indivior, Inspharm and Gilead. All other faculty members declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.

Experts discuss access to opioid agonist treatment in prison, how this varies between countries, and how access can be improved. 

Panellists: Dr Gabriele Fischer, Prof. Liljana Ignjatova, Dr Andrej Kastelic

Learning objective: After watching this video, learners will be able to describe the importance of OAT access in prison.

Disclosures: Dr Andrej Kastelic declares speaker fees for Indivior, Inspharm and Gilead. All other faculty members declare no relevant financial relationships.

Funding: This activity is supported by an educational grant from Indivior. The educational content has been developed by Europad in conjunction with Liberum IME; Indivior has had no influence on the content of this education.